Stay updated with breaking news from Richardh Scheller. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
DICE Therapeutics, Inc. (NASDAQ:DICE – Get Rating) saw a large decrease in short interest in the month of May. As of May 15th, there was short interest totalling 8,010,000 shares, a decrease of 9.0% from the April 30th total of 8,800,000 shares. Currently, 20.8% of the company’s shares are sold short. Based on an average […]
Sands Capital Ventures LLC lessened its stake in DICE Therapeutics, Inc. (NASDAQ:DICE – Get Rating) by 12.7% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 2,748,970 shares of the company’s stock after selling 400,000 shares during the period. DICE Therapeutics […]
Shares of DICE Therapeutics, Inc. (NASDAQ:DICE – Get Rating) have been assigned a consensus rating of “Buy” from the eleven analysts that are presently covering the company, MarketBeat reports. Seven analysts have rated the stock with a buy rating. The average 1 year price objective among brokers that have issued ratings on the stock in […]
DICE Therapeutics, Inc. (NASDAQ:DICE – Get Rating) Director Richard H. Scheller sold 84,097 shares of the stock in a transaction that occurred on Friday, May 5th. The stock was sold at an average price of $38.51, for a total transaction of $3,238,575.47. Following the completion of the transaction, the director now owns 8,427 shares in […]
Une patrouille a essuyé des tirs près d'Inal, au cours d'une course poursuite engagée contre un groupe de trafiquants, a annoncé l'armée mauritanienne (...)